BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12167560)

  • 1. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.
    Xiong H; Suzuki H; Sugiyama Y; Meier PJ; Pollack GM; Brouwer KL
    Drug Metab Dispos; 2002 Sep; 30(9):962-9. PubMed ID: 12167560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
    Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment.
    Studenberg SD; Brouwer KL
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1022-7. PubMed ID: 1602370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1.
    Zamek-Gliszczynski MJ; Hoffmaster KA; Tian X; Zhao R; Polli JW; Humphreys JE; Webster LO; Bridges AS; Kalvass JC; Brouwer KL
    Drug Metab Dispos; 2005 Aug; 33(8):1158-65. PubMed ID: 15860656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions.
    Patel NJ; Zamek-Gliszczynski MJ; Zhang P; Han YH; Jansen PL; Meier PJ; Stieger B; Brouwer KL
    Mol Pharmacol; 2003 Jul; 64(1):154-9. PubMed ID: 12815171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phenobarbital and p-hydroxyphenobarbital glucuronide on acetaminophen metabolites in isolated rat hepatocytes: use of a kinetic model to examine the rates of formation and egress.
    Studenberg SD; Brouwer KL
    J Pharmacokinet Biopharm; 1993 Apr; 21(2):175-94. PubMed ID: 8229679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 5 (and 6)-carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liver.
    Zamek-Gliszczynski MJ; Xiong H; Patel NJ; Turncliff RZ; Pollack GM; Brouwer KL
    J Pharmacol Exp Ther; 2003 Feb; 304(2):801-9. PubMed ID: 12538836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute phenobarbital administration alters the disposition of acetaminophen metabolites in the rat.
    Brouwer KL
    Drug Metab Dispos; 1993; 21(6):1129-33. PubMed ID: 7905395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
    Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
    Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier.
    Brouwer KL; Jones JA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
    Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
    J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites.
    Slitt AL; Cherrington NJ; Maher JM; Klaassen CD
    Drug Metab Dispos; 2003 Sep; 31(9):1176-86. PubMed ID: 12920174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethynylestradiol increases expression and activity of rat liver MRP3.
    Ruiz ML; Villanueva SS; Luquita MG; Vore M; Mottino AD; Catania VA
    Drug Metab Dispos; 2006 Jun; 34(6):1030-4. PubMed ID: 16554369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats.
    Chen C; Hennig GE; Manautou JE
    Drug Metab Dispos; 2003 Jun; 31(6):798-804. PubMed ID: 12756215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance-associated protein 2 is primarily responsible for the biliary excretion of fexofenadine in mice.
    Tian X; Zamek-Gliszczynski MJ; Li J; Bridges AS; Nezasa K; Patel NJ; Raub TJ; Brouwer KL
    Drug Metab Dispos; 2008 Jan; 36(1):61-4. PubMed ID: 17913796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney.
    Li CY; Basit A; Gupta A; Gáborik Z; Kis E; Prasad B
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105350. PubMed ID: 30959153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- mice.
    Zamek-Gliszczynski MJ; Nezasa K; Tian X; Bridges AS; Lee K; Belinsky MG; Kruh GD; Brouwer KL
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1485-91. PubMed ID: 16988054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.
    Lecureux L; Dieter MZ; Nelson DM; Watson L; Wong H; Gemzik B; Klaassen CD; Lehman-McKeeman LD
    Toxicol Sci; 2009 Apr; 108(2):482-91. PubMed ID: 19211616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
    Chu XY; Huskey SE; Braun MP; Sarkadi B; Evans DC; Evers R
    J Pharmacol Exp Ther; 2004 Apr; 309(1):156-64. PubMed ID: 14722317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
    Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.